Back to BETA
Clear

Board Meetings for BETA

Detailed list of historic and upcoming board meetings.

SymbolCompanyMeeting DatePurposeDescriptionLinks
BETABeta Drugs Limited27 Nov 2024Other business mattersTo consider other business matters 1. To consider & approve the allotment of 100 fully paid-up equity shares of the Company of face value of Rs. 10 each, at a price of Rs 1,653.40 per Equity Share including a premium of Rs. 1,643.40 per Equity Share and 7,07,651 fully paid up unsecured compulsory convertible debentures of the Company ( CCDs ) of face value of Rs. 1,653.40 each under Preferential Issue, pursuant to approval obtained from shareholders in Extra Ordinary General Meeting held on 12th November, 2024.2. To consider, approve & adopt the restated Article of Association of the company, subject to the approval of shareholders of the company in their meeting.
PDF
BETABeta Drugs Limited06 Nov 2024Board Meeting IntimationBETA DRUGS LIMITED has informed the Exchange about Board Meeting to be held on 06-Nov-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2024 .
PDF
BETABeta Drugs Limited06 Nov 2024Financial ResultsTo consider and approve the financial results for the period ended September 30, 2024
PDF
BETABeta Drugs Limited19 Oct 2024Fund RaisingTo consider Fund Raising
PDF
BETABeta Drugs Limited19 Oct 2024BETA DRUGS LIMITED has informed the Exchange about Board Meeting to be held on 19-Oct-2024 to consider Fund raising.Board Meeting Intimation
PDF
BETABeta Drugs Limited14 May 2024BETA DRUGS LIMITED has informed the Exchange about Board Meeting to be held on 14-May-2024 to inter-alia consider and approve the Audited Financial results of the Company for the Yearly ended March 2024 .Board Meeting Intimation
PDF
BETABeta Drugs Limited14 May 2024Financial ResultsTo consider and approve the financial results for the period ended March 31, 2024
PDF
BETABeta Drugs Limited07 Nov 2023BETA DRUGS LIMITED has informed the Exchange about Board Meeting to be held on 07-Nov-2023 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2023 and Other business.Board Meeting Intimation
PDF
BETABeta Drugs Limited07 Nov 2023Financial Results/Other business mattersTo consider and approve the financial results for the period ended September 30, 2023. 2. To consider the Migration of the Equity shares of the Company from Emerge-SME Platform of National Stock Exchange of India Limited ( NSE Emerge ) to the Main board of National Stock Exchange of India Limited & Bombay Stock Exchange of India Limited.
PDF
BETABeta Drugs Limited08 May 2023Financial ResultsTo consider and approve the financial results for the period ended March 31, 2023
PDF
BETABeta Drugs Limited08 May 2023BETA DRUGS LIMITEDhas informed the Exchange about Board Meeting to be held on 08-May-2023to inter-alia consider and approve the Audited financial results of the Company for the Yearly ended March 2023 .Board Meeting Intimation
PDF
BETABeta Drugs Limited27 Oct 2022Financial resultsBeta Drugs Limited has informed the Exchange about Board Meeting to be held on 27-Oct-2022 to consider financial statements for the period ended September 2022
PDF
BETABeta Drugs Limited27 Apr 2022Financial resultsBeta Drugs Limited has informed the Exchange about Board Meeting to be held on 27-Apr-2022 to consider financial statements for the period ended March 2022
PDF
BETABeta Drugs Limited25 Oct 2021Financial ResultsTo consider and approve the financial results for the period ended September 30, 2021
PDF
BETABeta Drugs Limited31 Aug 2021Other business mattersTo consider other business matters
PDF
Showing page 2 of 4 (55 total items)
PreviousNext